Skip to main content
. 2023 Jan 13;19(1):107–115. doi: 10.5114/aoms/130927

Table III.

Characteristics of patients who underwent surgical treatment for prostate cancer (radical prostatectomy) in pre-COVID and COVID period

Variable Overall n (%)/mean (IQR) Pre-COVID n (%)/mean (IQR) COVID n (%)/mean (IQR) P-value
Age 65.1 (8) 65.3 (8) 64.9 (8) 0.59
ASA: 1 35 (9%) 20 (10.1%) 15 (7.9%) 0.73
2 284 (73%) 142 (71.4%) 142 (74.7%)
3 69 (17.7%) 36 (18.1%) 33 (17.4%)
≥ 4 1 (0.3%) 1 (0.5%) 0 (0%)
Hgb [g/dl] 14.5 (1.6) 14.6 (1.6) 14.5 (1.6) 0.76
Laparoscopy 307 (78.9%) 158 (83.2%) 149 (74.9%) 0.048
eLND 201 (48.3%) 102 (53.7%) 99 (49.8%) 0.48
PSA [ng/ml] 12.3 (8.1) 12.2 (7) 12.4 (9.3) 0.81
Grade group: I 157 (41.3%) 86 (46%) 71 (36.7%) 0.028
II 107 (28.2%) 56 (30%) 51 (26.4%)
III 62 (16.3%) 24 (12.8%) 38 (19.7%)
IV 43 (11.3%) 14 (7.5%) 29 (15%)
V 11 (2.9%) 7 (3.7%) 4 (2.1%)
DRE (+) 207 (54.5%) 90 (47.4%) 117 (61.6%) 0.007
cT: cT1 140 (36%) 77 (40.5%) 63 (31.2%) 0.13
cT2 206 (53%) 91 (47.9%) 115 (57.8%)
≥ cT3 43 (11.1%) 22 (11.6%) 21 (10.6%)
LOH 5.8 (2) 5.7 (3) 5.8 (3) 0.084

ASA – American Society of Anesthesiologists score, Hgb – haemoglobin, eLND- extended lymph node dissection, PSA – prostate-specific antigen, DRE – digital rectal examination, cT – clinical local staging, LOH – length of hospitalisation.